Kymera Therapeutics

Kymera Therapeutics Announces Expansion of Scientific Advisory Board to Advance Pre-Clinical Molecules Toward the Clinic

New members offer world-class expertise in human genetics, translational research and drug discovery in oncology, inflammation and immunology Cambridge, Mass. (Dec. 18, 2018) – Kymera Therapeutics Inc., a biotechnology company pioneering targeted protein degradation to create breakthrough medicines